| Opiate Addiction
Suboxone vs Zubsolv
Side-by-side clinical, coverage, and cost comparison for opiate addiction.Deep comparison between: Suboxone vs Zubsolv with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsZubsolv has a higher rate of injection site reactions vs Suboxone based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Zubsolv but not Suboxone, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Suboxone
Zubsolv
At A Glance
Sublingual/buccal film
Daily
Partial opioid agonist/antagonist
Sublingual
Daily
Opioid partial agonist/antagonist
Indications
- Opiate Addiction
- Opiate Addiction
Dosing
Opiate Addiction Induction Day 1: up to 8 mg/2 mg buprenorphine/naloxone in divided doses; Day 2: up to 16 mg/4 mg as a single dose; maintenance: 4 mg/1 mg to 24 mg/6 mg per day as a single daily dose sublingually or buccally, adjusted based on clinical response.
Opiate Addiction Induction: up to 5.7 mg/1.4 mg on Day 1 in divided doses, up to 11.4 mg/2.9 mg on Day 2; maintenance: 2.9 mg/0.71 mg to 17.2 mg/4.2 mg once daily sublingually, adjusted to clinical response.
Contraindications
- Hypersensitivity to buprenorphine or naloxone, including anaphylactic shock
- History of hypersensitivity to buprenorphine or naloxone
Adverse Reactions
Most common (>=5%) Headache, withdrawal syndrome, pain, nausea, constipation, insomnia, sweating, vomiting, asthenia, chills, vasodilation
Serious Respiratory and CNS depression, neonatal opioid withdrawal syndrome, adrenal insufficiency, opioid withdrawal, hepatitis and hepatic events, hypersensitivity reactions, orthostatic hypotension, elevation of cerebrospinal fluid pressure, elevation of intracholedochal pressure
Postmarketing Peripheral edema, stomatitis, glossitis, mouth or tongue blistering and ulceration, serotonin syndrome, anaphylaxis, androgen deficiency, dental decay, hypoglycemia, opioid-induced esophageal dysfunction
Most common (>=5%) Nausea, vomiting, headache, constipation, insomnia, sweating, pain, asthenia, anxiety, depression, rhinitis
Serious Respiratory depression, CNS depression, neonatal opioid withdrawal syndrome, adrenal insufficiency, opioid withdrawal, hepatitis, hypersensitivity reactions, orthostatic hypotension, elevation of cerebrospinal fluid pressure, elevation of intracholedochal pressure
Postmarketing Peripheral edema, serotonin syndrome, anaphylaxis, androgen deficiency, dental decay, glossodynia, glossitis, oral mucosal erythema, oral hypoesthesia, stomatitis, hypoglycemia, opioid-induced esophageal dysfunction
Pharmacology
Buprenorphine is a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor, producing ceiling-limited opioid agonist effects; naloxone is a potent mu-opioid antagonist that, when administered parenterally, precipitates opioid withdrawal in dependent individuals, deterring injection misuse of the combination product.
Buprenorphine is a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor; naloxone is a potent mu-opioid receptor antagonist that deters parenteral misuse by precipitating withdrawal in opioid-dependent individuals when administered by routes other than sublingual.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Suboxone
- Covered on 5 commercial plans
- PA (1/12) · Step Therapy (0/12) · Qty limit (12/12)
Zubsolv
- Covered on 5 commercial plans
- PA (5/12) · Step Therapy (0/12) · Qty limit (10/12)
UnitedHealthcare
Suboxone
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (4/8)
Zubsolv
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (4/8)
Humana
Suboxone
- Covered on 0 commercial plans
- PA (0/3) · Step Therapy (0/3) · Qty limit (1/3)
Zubsolv
- Covered on 0 commercial plans
- PA (0/3) · Step Therapy (0/3) · Qty limit (1/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Suboxone.
No savings programs available for Zubsolv.
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
SuboxoneView full Suboxone profile
ZubsolvView full Zubsolv profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.